tsRNA-GlyGCC promotes colorectal cancer progression and 5-FU resistance by regulating SPIB.

Autor: Xu, Rong¹ (AUTHOR), Du, Ashuai² (AUTHOR), Deng, Xinpei³ (AUTHOR), Du, Wei¹ (AUTHOR), Zhang, Kaiying³ (AUTHOR), Li, Jianbo⁴ (AUTHOR), Lu, Yingxue² (AUTHOR), Wei, Xiaoli³ (AUTHOR) weixl@sysucc.org.cn, Yang, Qinglong⁵ (AUTHOR) 715581746@qq.com, Tang, Hailin³ (AUTHOR) tanghl@sysucc.org.cn

Publikováno v: Journal of Experimental & Clinical Cancer Research (17569966). 8/17/2024, p1-17. 17p.

Exosomal circRNA-001264 promotes AML immunosuppression through induction of M2-like macrophages and PD-L1 overexpression

Autor: Du, Ashuai, Yang, Qinglong, Sun, Xiaoying, Zhao, Qiangqiang

Publikováno v: In International Immunopharmacology November 2023 124 Part A

Host E3 ligase HUWE1 attenuates the proapoptotic activity of the MERS-CoV accessory protein ORF3 by promoting its ubiquitin-dependent degradation

Autor: Zhou, Yuzheng, Zheng, Rong, Liu, Sixu, Disoma, Cyrollah, Du, Ashuai, Li, Shiqin, Chen, Zongpeng, Dong, Zijun, Zhang, Yongxing, Li, Sijia, Liu, Pinjia, Razzaq, Aroona, Chen, Xuan, Liao, Yujie, Tao, Siyi, Liu, Yuxin, Xu, Lunan, Zhang, Qianjun, Peng, Jian, Deng, Xu, Li, Shanni, Jiang, Taijiao, Xia, Zanxian

Publikováno v: In Journal of Biological Chemistry February 2022 298(2)

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

M6A-mediated upregulation of circMDK promotes tumorigenesis and acts as a nanotherapeutic target in hepatocellular carcinoma.

Autor: Du, Ashuai^1,2 (AUTHOR), Li, Shiqin¹ (AUTHOR), Zhou, Yuzheng¹ (AUTHOR), Disoma, Cyrollah¹ (AUTHOR), Liao, Yujie¹ (AUTHOR), Zhang, Yongxing¹ (AUTHOR), Chen, Zongpeng¹ (AUTHOR), Yang, Qinglong³ (AUTHOR), Liu, Pinjia¹ (AUTHOR), Liu, Sixu¹ (AUTHOR), Dong, Zijun¹ (AUTHOR), Razzaq, Aroona¹ (AUTHOR), Tao, Siyi¹ (AUTHOR), Chen, Xuan¹ (AUTHOR), Liu, Yuxin¹ (AUTHOR), Xu, Lunan¹ (AUTHOR), Zhang, Qianjun⁴ (AUTHOR), Li, Shanni¹ (AUTHOR), Peng, Jian⁵ (AUTHOR), Xia, Zanxian^1,6 (AUTHOR) xiazanxian@sklmg.edu.cn

Publikováno v: Molecular Cancer. 5/6/2022, Vol. 21 Issue 1, p1-18. 18p.